Nateglinide

SKU: orb1307803

Description

Nateglinide is an amino acid-derived oral hypoglycemic agent used to treat type 2 diabetes by stimulating pancreatic insulin secretion. It is employed in research on diabetes pathophysiology and drug mechanisms, both in vitro and in animal models. Rare cases of clinically apparent acute liver injury have been associated with its use.

Research Area

Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery, Protein Biochemistry

Key Properties

• CAS Number: 105816-04-4
• MW: 317.42
• Purity: 99.94% (May vary between batches)
• Formula: C₁₉H₂₇NO₃
• SMILES: C(N[C@H](CC1=CC=CC=C1)C(O)=O)(=O)[C@H]2CC[C@H](C(C)C)CC2
• Target: Potassium Channel,Proteasome,PPAR
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.3 mM);DMSO:60 mg/mL (189.02 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Dipeptidyl Peptidase, diabetes, DPP, A4166, A-4166, A 4166, glucose, Inhibitor, insulin, inhibit, KcsA, Nateglinide, β-cell, short-acting, Potassium Channel, Senaglinide, PotassiumChannel, PPARγ

Compound Identifiers

PubChem CID

5311309